Biogen Inc
(BIIB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 977,000 | 393,400 | 1,161,500 | 912,600 | 980,900 |
| Depreciation Amortization | 440,600 | 191,600 | 526,300 | 354,700 | 229,700 |
| Income taxes - deferred | -47,100 | 39,900 | -305,800 | -377,700 | -170,900 |
| Accounts receivable | 12,300 | 43,700 | 61,300 | -76,500 | 21,800 |
| Other Working Capital | -417,300 | -228,700 | -648,700 | -600 | -315,000 |
| Other Operating Activity | 213,500 | 113,300 | 752,600 | 722,200 | 195,800 |
| Operating Cash Flow | $1,179,000 | $553,200 | $1,547,200 | $1,534,700 | $942,300 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -79,400 | -45,900 | -277,000 | -211,800 | -137,600 |
| Net Acquisitions | 406,800 | N/A | -6,926,100 | -5,547,500 | 788,100 |
| Purchase Of Investment | N/A | N/A | -5,140,700 | -5,140,700 | -4,120,300 |
| Sale Of Investment | 57,500 | 55,600 | 8,288,500 | 7,487,000 | 1,785,400 |
| Purchase Sale Intangibles | -84,100 | -75,000 | -34,400 | -34,400 | -21,000 |
| Other Investing Activity | 15,600 | -75,700 | -45,700 | -35,700 | -22,100 |
| Investing Cash Flow | $400,500 | $-66,000 | $-4,101,000 | $-3,448,700 | $-1,706,500 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | N/A | 997,200 | 997,200 | N/A |
| Debt Repayment | -650,000 | -400,000 | -809,900 | -159,900 | N/A |
| Other Financing Activity | -34,800 | -39,600 | -38,000 | -41,900 | -53,200 |
| Financing Cash Flow | $-684,800 | $-439,600 | $149,300 | $795,400 | $-53,200 |
| Exchange Rate Effect | -35,700 | -23,100 | 35,100 | -12,800 | 15,900 |
| Beginning Cash Position | 1,049,900 | 1,049,900 | 3,419,300 | 3,419,300 | 3,419,300 |
| End Cash Position | 1,908,900 | 1,074,400 | 1,049,900 | 2,287,900 | 2,617,800 |
| Net Cash Flow | $859,000 | $24,500 | $-2,369,400 | $-1,131,400 | $-801,500 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,179,000 | 553,200 | 1,547,200 | 1,534,700 | 942,300 |
| Capital Expenditure | -79,400 | -45,900 | -277,000 | -211,800 | -137,600 |
| Free Cash Flow | 1,099,600 | 507,300 | 1,270,200 | 1,322,900 | 804,700 |